Abstract:Whilst the influence of intestinal microbiota has been shown in many diseases such as irritable bowel syndrome, colorectal cancer, and aging, investigations are still scarce on its role in altering the nature of other infective organisms. Here we studied the association and interaction of Blastocystis sp. and human intestinal microbiota. In this study, we investigated the gut microbiome of Blastocystis sp.-free and Blastocystis sp. ST3-infected individuals who are symptomatic and asymptomatic. We tested if the expression of phenotype and pathogenic characteristics of Blastocystis sp. ST3 was influenced by the alteration of its accompanying microbiota. Blastocystis sp. ST3 infection alters bacterial composition. Its presence in asymptomatic individuals showed a significant effect on microbial richness compared to symptomatic ones. Inferred metagenomic findings suggest that colonization of Blastocystis sp. ST3 could contribute to the alteration of microbial functions. For the first time, we demonstrate the influence of bacteria on Blastocystis sp. pathogenicity. When Blastocystis sp. isolated from a symptomatic individual was co-cultured with bacterial suspension of Blastocystis sp. from an asymptomatic individual, the parasite demonstrated increased growth and reduced potential pathogenic expressions. This study also reveals that Blastocystis sp. infection could influence microbial functions without much effect on the microbiota diversity itself. Our results also demonstrate evidence on the influential role of gut microbiota in altering the characteristics of the parasite, which becomes the basis for the contradictory findings on the parasite's pathogenic role seen across different studies. Our study provides evidence that asymptomatic Blastocystis sp. in a human gut can be triggered to show pathogenic characteristics when influenced by the intestinal microbiota. Single-cell eukaryotes in the intestinal microbiota are increasingly gaining attention for their ability to influence microbiota composition. Blastocystis sp. is no exception. This study for the first time demonstrates gut microbiota alteration due to the colonization of Blastocystis sp. ST 3 in symptomatic and asymptomatic conditions. Colonization of Blastocystis sp. ST3, regardless of symptoms, significantly alters the diversity and microbiota composition. The abundance of Prevotella sp. was significantly elevated in symptomatic Blastocystis sp. carriage. Inferred metagenomic findings revealed that predicted metabolic functions were altered in Blastocystis sp. carriage in symptomatic and asymptomatic conditions. The current study demonstrates a bidirectional influence that seems to be crucial in Blastocystis sp.–microbiota interaction. Altering the accompanying microbiota of a symptomatic Blastocystis sp. with bacterial suspension from an asymptomatic condition resulted in the protozoan exhibiting asymptomatic characteristics. This implies, for the first time the effect of accompanying microbiota on Blastocystis sp. phenotypic characteristics. The findings lead to a postulation that a harmless protozoan parasite can be turned harmful by its accompanying microbiota in the gut.

An Update on Blastocystis: Possible Mechanisms of Blastocystis-Mediated Colorectal Cancer

Blastocystis: A Mysterious Member of the Gut Microbiome

Colorectal cancer and Blastocystis sp. infection

Blastocystis and its pathogenic potential: latest aspects

Surface ultrastructure, protein profile and zymography of Blastocystis species isolated from patients with colorectal carcinoma

Epidemiology and subtype distribution of Blastocystis in humans: A review

Interactions Between a Pathogenic Blastocystis Subtype and Gut Microbiota: in Vitro and in Vivo Studies

Experimental colonization with Blastocystis ST4 is associated with protective immune responses and modulation of gut microbiome in a DSS-induced colitis mouse model

Colonization with two different Blastocystis subtypes in DSS-induced colitis mice is associated with strikingly different microbiome and pathological features

Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity

Oh My Aching Gut: Irritable Bowel Syndrome, Blastocystis, and Asymptomatic Infection

Colonization with ubiquitous protist Blastocystis ST1 ameliorates DSS-induced colitis and promotes beneficial microbiota and immune outcomes

[Progress of researches on Blastocystis hominis infection among patients with inflammatory bowel disease and irritable bowel syndrome]

Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFα, IL-6, IL-10, IL-4)

How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

Colorectal cancer: role of commensal bacteria and bystander effects

Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy

Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation

Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer

Molecular epidemiology and subtyping of Blastocystis sp. and its subtypes in celiac patients; a case control study